-
EP1267926
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1267926
| EP1267926 - METHOD OF INHIBITING STENOSIS AND RESTENOSIS WITH A MIXTURE OF ANTIBODIES ANTI CD18 AND ANTI CCR2 [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 07.12.2012 Database last updated on 09.09.2024 | Most recent event Tooltip | 07.12.2012 | Application deemed to be withdrawn | published on 09.01.2013 [2013/02] | Applicant(s) | For all designated states MILLENNIUM PHARMACEUTICALS, INC. 75 Sidney Street Cambridge Massachusetts 02139 / US | [N/P] |
| Former [2003/01] | For all designated states Millennium Pharmaceuticals, Inc. 75 Sidney Street Cambridge, Massachusetts 02139 / US | Inventor(s) | 01 /
HORVATH, Christopher, J. 209 Plain Street Taunton, MA 02780 / US | 02 /
RAO, Patricia, E. 112 Pope Road Acton, MA 01720 / US | [2003/01] | Representative(s) | Lock, Graham James, et al Fry Heath & Spence LLP Unit A, Faraday Court Faraday Road Crawley, West Sussex RH10 9PU / GB | [N/P] |
| Former [2003/01] | Lock, Graham James, et al Fry Heath & Spence LLP The Old College, 53 High Street Horley, Surrey RH6 7BN / GB | Application number, filing date | 01918697.2 | 15.03.2001 | [2003/01] | WO2001US08266 | Priority number, date | US20000528267 | 17.03.2000 Original published format: US 528267 | [2003/01] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO0170266 | Date: | 27.09.2001 | Language: | EN | [2001/39] | Type: | A2 Application without search report | No.: | EP1267926 | Date: | 02.01.2003 | Language: | EN | The application published by WIPO in one of the EPO official languages on 27.09.2001 takes the place of the publication of the European patent application. | [2003/01] | Search report(s) | International search report - published on: | EP | 04.07.2002 | Classification | IPC: | A61K39/395, A61P9/10 | [2003/01] | CPC: |
C07K16/2866 (EP,US);
A61P9/10 (EP);
A61P9/14 (EP);
C07K16/2845 (EP,US);
A61K2039/505 (EP,US);
A61M25/104 (EP,US);
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2003/01] | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | RO | Not yet paid | SI | Not yet paid | Title | German: | VERFAHREN ZUR HEMMUNG VON STENOSE UND RESTENOSE MIT EINER MISCHUNG VON ANTIKÖRPERN GEGEN CD18 UND CCR2 | [2003/01] | English: | METHOD OF INHIBITING STENOSIS AND RESTENOSIS WITH A MIXTURE OF ANTIBODIES ANTI CD18 AND ANTI CCR2 | [2003/01] | French: | METHODE D'INHIBITION DE LA STENOSE ET DE LA RESTENOSE | [2003/01] | Entry into regional phase | 17.10.2002 | National basic fee paid | 17.10.2002 | Designation fee(s) paid | 17.10.2002 | Examination fee paid | Examination procedure | 10.08.2001 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 17.10.2002 | Examination requested [2003/01] | 27.05.2008 | Despatch of a communication from the examining division (Time limit: M06) | 19.11.2008 | Reply to a communication from the examining division | 02.03.2012 | Despatch of a communication from the examining division (Time limit: M04) | 13.07.2012 | Application deemed to be withdrawn, date of legal effect [2013/02] | 22.08.2012 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2013/02] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 27.05.2008 | Fees paid | Renewal fee | 11.03.2003 | Renewal fee patent year 03 | 15.03.2004 | Renewal fee patent year 04 | 14.03.2005 | Renewal fee patent year 05 | 29.03.2006 | Renewal fee patent year 06 | 28.03.2007 | Renewal fee patent year 07 | 27.03.2008 | Renewal fee patent year 08 | 26.03.2009 | Renewal fee patent year 09 | 25.03.2010 | Renewal fee patent year 10 | 28.03.2011 | Renewal fee patent year 11 | 26.03.2012 | Renewal fee patent year 12 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]WO9412214 (PROTEIN DESIGN LABS INC [US], et al) [Y] 1-29 * claims 1-30 *; | [Y]WO0005265 (LEUKOSITE INC [US], et al) [Y] 1-29 * claims 1-54 *; | [A]US5985279 (WALDMANN HERMAN [GB], et al) [A] 30 * column 1, line 48 - line 60; claims 1-27 *; | [A]WO9842360 (MASSACHUSETTS INST TECHNOLOGY [US], et al) [A] 1-33 * claims 1-17 *; | [A] - JOHNSTON B ET AL, "Chronic inflammation upregulates chemokine receptors and induces neutrophil migration to monocyte chemoattractant protein-1.", JOURNAL OF CLINICAL INVESTIGATION, (1999 MAY) 103 (9) 1269-76., XP002178702 [A] 1-33 * the whole document * DOI: http://dx.doi.org/10.1172/JCI5208 | [PX] - WELT, FREDERICK G. P. (1) ET AL, "Targeting CCR - 2 or CD18 inhibits experimental in- stent restenosis in primates. Inhibitory potential depends on type of injury and leukocytes targeted.", CIRCULATION, (OCTOBER 31, 2000) VOL. 102, NO. 18 SUPPLEMENT, PP. II.247. PRINT. MEETING INFO.: ABSTRACTS FROM SCIENTIFIC SESSIONS 2000 NEW ORLEANS, LOUISIANA, USA NOVEMBER 12-15, 2000, XP001024480 [PX] 1-29 * abstract * |